提供者:上海创凌生物科技有限公司 发布时间:2020/6/28 13:51:05 阅读次数:2021次 进入该公司店铺
西南大学生命科学学院教育部创新重点实验室
使用zeta life,Advanced DNA RNA转染试剂
高效率转染HCT-116, SW480, HT-29人结直肠癌细胞
2020-4-28发表文章已见刊
发表文章转染条件
A、HCT-116, SW480, HT-29人结直肠癌细胞
B、AURKA质粒
C、转染细胞融合度50%
D、96孔板每孔使用0.5μg质粒DNA
6孔每孔使用10 ug质粒DNA
(注意:本实验中用到的细胞密度、转染质粒DNA用量不适用于LIPO3000/2000)
发表文章部分内容
Overexpression of AURKA Plasmid for AURKA overexpression was obtained from VectorBuilder. Details about plasmid containing the AURKA gene can be found at https://www.vectorbuilder.cn/vector/VB190802-1063ncc. html. colon cancer cells (HCT-116, SW480, HT-29) were seeded at 50% confluency for 24 h in six-well and 96-well plates. Plasmid (10 ug per-well for six-well and 0.5 μg per-well for 96 plates) and the Advanced DNA RNA transfection(zeta life,USA) reagent were mixed in equal proportionsand added to the cell culture medium for 6 h. DOX (1 μg/ml) was added to induce the expression of AURKA. After addition of DOX and PAL for 36 h, cell viability was measured by MTT and apoptosis was detected by。
PAL exerts anti-colon cancer effects by targeting AURKA. (A) PAL promotes apoptosis in colon cancer cells (HCT-116, SW480) in a dose-dependent manner. (B) PAL promotes G2/M phase arrest in colon cancer cells (HCT-116, SW480) in a dose-dependent manner. (C) The expression of AURKA after DOX treatment for 24 h. (D) Cell density after PAL treatment for 24 h in the cells (HCT-116, SW480) transfected with AURKA overexpression plasmids. DOX is an inducer of AURKA
expression in plasmids. (E) Effect of PAL detected by MTT assay on the proliferation ability of colon cancer cells transfected with AURKA overexpression plasmids. (F) Effects of PAL detected by.
zeta life,Advanced DNA RNA转染试剂信息如下:
产品名称 | 货号 | 规格 |
Advanced DNA RNA 转染试剂 | AD600025 | 0.25ML |
Advanced DNA RNA 转染试剂 | AD600050 | 0.5 |
Advanced DNA RNA 转染试剂 | AD600075 | 0.75 |
Advanced DNA RNA 转染试剂 | AD600150 | 1.5ML |
Advanced DNA RNA 转染试剂 | AD600500 | 5ML |
Advanced DNA RNA 转染试剂 | AD601000 | 10ML |
① 凡本网注明"来源:阿仪网"的所有作品,版权均属于阿仪网,未经本网授权不得转载、摘编或利 用其它方式使用。已获本网授 权的作品,应在授权范围内使用,并注明"来源:阿仪网"。违者本网将追究相关法律责任。
② 本信息由注册会员:上海创凌生物科技有限公司发布并且负责版权等法律责任。
设为首页 | 加入收藏 | 关于阿仪 | 本站服务 | 广告服务 | 智能建站 | 联系我们 | 网站地图 | 友情连接
最新产品 最新资讯 技术文章 公司动态 最新Top200行业热词 最新仪器行业专场 最新求购 分类浏览优质仪器文献最新发布搜索标签
互联网药品信息服务资格证书:(浙)-非经营性2019-0043 增值电信业务经营许可证:浙B2-20190746
Copyright 2009-2019 app17.com,all rights reserved ICP备案号:浙ICP备08105869号
会员服务咨询:18158115302 客服热线:0571-85363692 采购技术交流群号:187637045
版权声明